Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review

Table 5 Outcomes of patients with new-onset atrial fibrillation

Author, year [ref]	ICU LOS (days, mean)	Hospital LOS (days, mean)	Stroke (%)
Seguin P, 2004 [50]	16 vs. 7 (p = 0.0001)	34 vs. 22 (p = 0.009)	NA
Seguin P, 2006 [51]	22 vs. 10 (p < 0.001)	32 vs. 25 (p = 0.259)	NA
Arora S, 2007 [52]	10 vs. 4^a (NS)	47 vs. 22^a (NS)	NA
Christian SA, 2008 [26]	17.7 vs. 8.3 (p = 0.003)	32.1 vs. 28.5 (p = 0.68)	NA
Meierhenrich R, 2010 [53]	30 vs. 17^ab (p = 0.017)	NA	NA
Walkey AJ, 2011 [54]	NA	NA	2.6 vs. 0.7 (p < 0.0001)
Kanji S, 2012 [55]	10^ac	24^ac	0
Tongyaoo S, 2013 [56]	NA	NA	5.9 vs. 2.0^d

Atrial fibrillation vs. no atrial fibrillation.
AF atrial fibrillation, LOS length of stay, NA not available, NS not significant.
^aMedian.
^bData focusing on septic shock patients.
^cData with new-onset AF alone.
^d p value not provided.

ISSN: 2052-0492